GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by John G Ullman & Associates Inc.

John G Ullman & Associates Inc. lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 93.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 57,916 shares of the company's stock after purchasing an additional 27,931 shares during the quarter. John G Ullman & Associates Inc.'s holdings in GE HealthCare Technologies were worth $4,478,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of GEHC. Vanguard Group Inc. boosted its stake in GE HealthCare Technologies by 14.7% in the third quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company's stock worth $3,029,917,000 after buying an additional 5,693,244 shares in the last quarter. Invesco Ltd. boosted its stake in GE HealthCare Technologies by 21.4% in the third quarter. Invesco Ltd. now owns 5,048,262 shares of the company's stock worth $343,484,000 after buying an additional 889,297 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in GE HealthCare Technologies by 7.8% in the third quarter. Bank of New York Mellon Corp now owns 4,380,408 shares of the company's stock worth $298,043,000 after buying an additional 315,808 shares in the last quarter. Northern Trust Corp boosted its stake in GE HealthCare Technologies by 8.9% in the third quarter. Northern Trust Corp now owns 4,205,506 shares of the company's stock worth $286,143,000 after buying an additional 342,040 shares in the last quarter. Finally, Gates Capital Management Inc. lifted its position in GE HealthCare Technologies by 17.5% in the third quarter. Gates Capital Management Inc. now owns 2,708,835 shares of the company's stock valued at $184,309,000 after purchasing an additional 402,900 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company's stock.

Analysts Set New Price Targets

Several analysts have weighed in on the company. Morgan Stanley boosted their price objective on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an "equal weight" rating in a research report on Monday, February 12th. Evercore ISI boosted their price objective on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an "outperform" rating in a research report on Thursday, April 4th. Mizuho upped their target price on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a "buy" rating in a report on Thursday, April 11th. UBS Group upgraded GE HealthCare Technologies from a "sell" rating to a "neutral" rating and upped their target price for the company from $66.00 to $88.00 in a report on Monday, February 12th. Finally, Citigroup upped their target price on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a "buy" rating in a report on Wednesday, April 3rd. Four analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies has an average rating of "Moderate Buy" and a consensus price target of $95.08.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock traded down $0.48 during trading on Friday, hitting $84.49. 2,022,572 shares of the company's stock traded hands, compared to its average volume of 3,393,032. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 1 year low of $62.35 and a 1 year high of $94.50. The stock has a market capitalization of $38.56 billion, a P/E ratio of 27.98, a PEG ratio of 2.96 and a beta of 0.94. The business has a 50-day simple moving average of $88.74 and a 200-day simple moving average of $77.82.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.07 by $0.11. The business had revenue of $5.20 billion for the quarter, compared to analysts' expectations of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The business's revenue for the quarter was up 5.3% on a year-over-year basis. During the same period last year, the firm posted $1.31 earnings per share. As a group, analysts forecast that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 annualized dividend and a yield of 0.14%. GE HealthCare Technologies's payout ratio is 3.97%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.